DIPNA PHARMACHEM LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.24 INR | +0.49% |
|
-2.25% | -22.63% |
| 04-25 | Dipna Pharmachem Limited announced a financing transaction | CI |
| 04-02 | Dipna Pharmachem Bags INR127.5 Million Order for Melamine Powder; Shares Jump 7% | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 728M 8.71M 685M | Sales 2023 | 999M 11.97M 941M | Capitalization | 150M 1.8M 141M |
|---|---|---|---|---|---|
| Net income 2022 | 11M 132K 10.36M | Net income 2023 | 9M 108K 8.47M | EV / Sales 2022 * | - |
| Net Debt 2022 | 99.8M 1.2M 93.97M | Net Debt 2023 | 99.67M 1.19M 93.85M | EV / Sales 2023 | 0.25 x |
| P/E ratio 2022 * |
-
| P/E ratio 2023 |
16.5
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 63.47% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.49% | ||
| 1 week | -2.25% | ||
| Current month | -2.25% | ||
| 1 month | -4.74% | ||
| 3 months | -28.35% | ||
| 6 months | -32.46% | ||
| Current year | -22.63% |
1 week
7.51
8.58
1 month
7.519.16
Current year
7.5117.38
1 year
7.5129.35
3 years
7.5133.60
5 years
7.5133.60
10 years
7.5133.60
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/06/24 | 8.24 | +0.49% | 69,000 |
| 06/06/24 | 8.2 | +2.24% | 126,000 |
| 05/06/24 | 8.02 | +1.65% | 111,000 |
| 04/06/24 | 7.89 | -6.29% | 198,000 |
| 03/06/24 | 8.42 | -0.12% | 144,000 |
Delayed Quote Bombay S.E., June 07, 2024 at 11:00 am
More quotes
Dipna Pharmachem Limited is an India-based trader, importer, and exporter in industrial chemical and pharmaceutical raw materials, active pharmaceutical ingredients (APIs), solvents, and formulation. The Company's products include albendazole, ambroxol HCL, amisulpride IP/BP, amoxicillin aripiprazole IP, artemether, azithromycin, cefixime, carbamezapin, calcium gluconate IP, cefadroxyl monohydrate IP/BP/EP cephalexin, clindamycin phosphate IP/BP/USP, clotrimazole, cetrimide powder, chlorhexidine base, chlorhexidine gluconate 20% solution, chlorhexidine hydrochloride, chlorhexidine acetate, dapoxetine HCL, dextromethorphan hydrobromic (DMR), diclofenac potassium, diclofenac sodium, dried alluminiumhydroxide IP, ferric ammounium citrate IP, ferrous ascorbate, folic acid IP, guaiphenesin IP, griseofulvin IP /BP, hydrocortisone acetate, ibuprofen IP, levofloxacin, lumefantrine, lidocaine base, lidocaine hydrochloride, lornoxicam, metronidazole plain/benzoate and mefenamic acid IP.
Sector
Specialty Chemicals
| 1st Jan change | Capi. | |
|---|---|---|
| -22.63% | 2.37M | |
| -10.66% | 8.66B | |
| +29.79% | 1.05B | |
| +63.41% | 172M | |
| +10.21% | 177M | |
| +36.99% | 144M | |
| +2.81% | 84.23M |
- Stock Market
- Equities
- DPL Stock